Financial Summary (All financials)
In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
Revenues | 2,527.2 | 2,319.9 | 2,191.7 | 2,202.1 | 2,416.7 | 3,245.8 | 4,152.7 | 5,180.7 |
Revenue growth | 8.9% | 5.8% | -0.5% | -8.9% | -25.5% | -21.8% | -19.8% | |
Cost of goods sold | 1,920.5 | 1,706.2 | 1,587.2 | 1,584.4 | 1,420.6 | 1,893.2 | 2,273.1 | 2,652.6 |
Gross profit | 606.7 | 613.7 | 604.5 | 617.7 | 996.1 | 1,352.6 | 1,879.6 | 2,528.1 |
Gross margin | 24.0% | 26.5% | 27.6% | 28.1% | 41.2% | 41.7% | 45.3% | 48.8% |
Selling, general and administrative | 318.4 | 322.0 | 413.2 | 440.0 | 491.2 | 535.0 | | |
Sales and marketing | | | | | | | 2,083.3 | 2,230.6 |
General and administrative | | | | | | | 640.0 | 964.2 |
EBITA | 301.9 | 303.8 | 292.2 | 177.7 | 504.9 | 789.7 | 1,219.1 | 2,075.1 |
EBITA margin | 11.9% | 13.1% | 13.3% | 8.1% | 20.9% | 24.3% | 29.4% | 40.1% |
Amortization of intangibles | 65.6 | 45.1 | 38.2 | 92.0 | 145.3 | 137.9 | 159.0 | 95.9 |
EBIT | 236.3 | 258.7 | 254.0 | 85.7 | 359.6 | 651.8 | 1,060.1 | 1,979.2 |
EBIT margin | 9.4% | 11.2% | 11.6% | 3.9% | 14.9% | 20.1% | 25.5% | 38.2% |
Pre-tax income | 196.0 | 183.7 | 1,210.1 | 42.3 | -969.2 | 460.1 | -1,167.6 | 1,855.0 |
Income taxes | 73.2 | 93.1 | 162.4 | 29.2 | -178.5 | 208.7 | 353.0 | 641.7 |
Tax rate | 37.3% | 50.7% | 13.4% | 69.0% | 18.4% | 45.4% | | 34.6% |
Earnings from continuing ops | 120.0 | 88.8 | 1,047.0 | 13.1 | -1,581.4 | 502.5 | -1,520.6 | 1,213.3 |
Earnings from discontinued ops | | | | | 8.2 | -2.9 | -6.0 | 182.1 |
Net income | 120.0 | 88.8 | 1,047.0 | 13.1 | -1,573.2 | 499.6 | -1,526.6 | 1,395.4 |
Net margin | 4.7% | 3.8% | 47.8% | 0.6% | -65.1% | 15.4% | -36.8% | 26.9% |
|
Diluted EPS | $1.45 | $1.08 | $11.20 | $0.12 | ($14.83) | $4.75 | ($14.37) | $11.47 |
Shares outstanding (diluted) | 83.0 | 82.0 | 93.5 | 106.0 | 106.6 | 105.8 | 105.8 | 105.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|